Youzhiyou Bio completed 200 million C round of financing
Youzhiyou Bio is a bispecific antibody drug developer, specializing in the biopharmaceutical business centered on tumor immunotherapy, focusing on the research and development and industrialization of bispecific antibody drugs. It has successively developed CD3 double antibody products in 3 clinical stages including M802, M701, and Y150, and several preclinical research and development stages. Recently, Youzhiyou […]
Youzhiyou Bio completed 200 million C round of financing Read More »